K. Lance Anderson Named to National Law Journal's 2019 Texas Trailblazers List
- Anderson, K. Lance
- In the News
Want to get our alerts?
Click “Subscribe Now” to get attorney insights on the latest developments in a range of services and industries.
Dickinson Wright PLLC is pleased to announce that K. Lance Anderson, member in our Austin office, has been named to the National Law Journal’s list of Texas Trailblazers.
The National Law Journal recognizes professionals who have moved the needle in the legal industry. Lance works with numerous clients within the innovation and research enterprise throughout Texas, assisting them on clinical and regulatory matters, transactions, strategic collaborations, and intellectual property matters.
“I am truly honored to be selected by the National Law Journal as a trailblazer in Texas. To have this area of my practice recognized is exciting to see. We are witnessing so many changes in our economy, and one key driver is the ever-increasing focus on innovation. The rise of innovation ecosystems, including those surrounding our universities and research institutions, is poised to leverage a new generation of entrepreneurial professionals,” said Lance.
Lance has extensive experience preparing and negotiating technology and intellectual property-focused transactions, as well as technology aspects of mergers and acquisitions, joint ventures, and other complex commercial transactions. A registered patent attorney, Lance also conducts patent prosecution, due diligence for licensing and acquisitions, technology agreements, and related operational legal issues on behalf of his clients. Lance is also a member of the firm’s management group.
The National Law Journal recognizes professionals who have moved the needle in the legal industry. Lance works with numerous clients within the innovation and research enterprise throughout Texas, assisting them on clinical and regulatory matters, transactions, strategic collaborations, and intellectual property matters.
“I am truly honored to be selected by the National Law Journal as a trailblazer in Texas. To have this area of my practice recognized is exciting to see. We are witnessing so many changes in our economy, and one key driver is the ever-increasing focus on innovation. The rise of innovation ecosystems, including those surrounding our universities and research institutions, is poised to leverage a new generation of entrepreneurial professionals,” said Lance.
Lance has extensive experience preparing and negotiating technology and intellectual property-focused transactions, as well as technology aspects of mergers and acquisitions, joint ventures, and other complex commercial transactions. A registered patent attorney, Lance also conducts patent prosecution, due diligence for licensing and acquisitions, technology agreements, and related operational legal issues on behalf of his clients. Lance is also a member of the firm’s management group.
Contacts
Recent Insights
- April 25, 2024 In the News Peter Westcott Joins Dickinson Wright Toronto Office
- April 24, 2024 In the News Jessica Bartlett Rejoins Dickinson Wright Washington, D.C. Office
- April 24, 2024 Industry Alerts FTC Declares Employees Free from Most Noncompetes, But How Far Does the Ban Go and Will It Last?
- April 23, 2024 In the News The Federation of Regulatory Counsel’s (FORC) Journal of Insurance Law and Regulation recently published an article by Daniel Cotter titled, “IPAS Brewing in Illinois.”
- April 22, 2024 Webinars Corporate Transparency Act – What's All the Hoopla
- April 22, 2024 In the News Two Dickinson Wright Lawyers Recognized in Who’s Who Legal Corporate Immigration 2024
- April 22, 2024 In the News Jacob Frenkel was recently interviewed for CNBC news, “Sam Bankman-Fried sentencing underway: Here’s what you need to know.”
- April 22, 2024 Industry Alerts Keep Your Server Permit: No Drinking on the Job
- April 22, 2024 In the News Daniel Cotter recently authored an article published in the Chicago Daily Law Bulletin, “Justices sound skeptical of claim over mifepristone, FDA actions.”